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Abstract 35	  
Introduction: Impaired wound healing has been widely reported in diabetes. 36	  
Linoleic acid (LA) accelerates the skin wound healing process in non-diabetic rats. 37	  
However, LA has not been tested in diabetic animals.  38	  
Objectives: We investigated whether oral administration of pure LA improves 39	  
wound healing in streptozotocin-induced diabetic rats.  40	  
Methods: Dorsal wounds were induced in streptozotocin-induced type-1 diabetic 41	  
rats treated or not with LA (0.22 g/kg b.w.) for 10 days. Wound closure was daily 42	  
assessed for two weeks. Wound tissues were collected at specific time-points and 43	  
used to measure fatty acid composition, and contents of cytokines, growth factors 44	  
and eicosanoids. Histological and qPCR analyses were employed to examine the 45	  
dynamics of cell migration during the healing process.  46	  
Results: LA reduced the wound area 14 days after wound induction. LA also 47	  
increased the concentrations of cytokine-induced neutrophil chemotaxis (CINC-2α48	  
β), tumor necrosis factor-α (TNF-α) and leukotriene B4 (LTB4), and reduced the 49	  
expression of macrophage chemoattractant protein-1 (MCP-1) and macrophage 50	  
inflammatory protein-1 (MIP-1). These results together with the histological 51	  
analysis, which showed accumulation of leukocytes in the wound early in the 52	  
healing process, indicate that LA brought forward the inflammatory phase and 53	  
improved wound healing in diabetic rats. Angiogenesis was induced by LA through 54	  
elevation in tissue content of key mediators of this process: vascular-endothelial 55	  
growth factor (VEGF) and angiopoietin-2 (ANGPT-2).  56	  
Conclusions: Oral administration of LA hastened wound closure in diabetic rats 57	  
by improving the inflammatory phase and angiogenesis.  58	  
 59	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Introduction 60	  
Wound healing is a physiological and essential process that must initiate as 61	  
soon as tissue damage occurs. It is divided into 4 phases: 1) the formation of a 62	  
clot, to stop the bleeding; 2) the inflammatory phase, with the recruitment of 63	  
immune cells and release of inflammatory mediators; 3) the proliferative phase, 64	  
with formation of granulation tissue, that plays an important role in new vessel 65	  
formation; 4) the remodeling phase, when the spatial reorganization of collagen 66	  
fibers and re-epithelization occur. Various cell types including neutrophils, 67	  
macrophages, fibroblasts, endothelial cells and keratinocytes, and a great number 68	  
of mediators (e.g. cytokines, lipid derived molecules, growth factors) orchestrate 69	  
the wound healing phases. Alterations in duration or intensity of the inflammatory 70	  
phase modify the onset of the next phase and hence impair the wound healing 71	  
process [1, 2].  72	  
Types 1 and 2 diabetes exhibit different etiologies, however, both are 73	  
associated with hyperglycemia and impairment in wound healing through 74	  
mechanisms involving exacerbation and chronification of the inflammatory 75	  
response [2-4]. Hard-to-heal wounds are a well-known diabetic complication [5]; 76	  
25% of diabetic patients had experienced a non-healing ulcer and 28% of them 77	  
underwent amputation related to poor wound healing [5]. Chronic wounds have an 78	  
imbalanced production of pro- and anti-inflammatory mediators such as TNF-α, 79	  
IL-1β, VEGF and IL-10 [6-8], hindering proper healing. The sustained expression 80	  
of pro-inflammatory cytokines and chemokines are associated with increased 81	  
numbers of neutrophils in late wound tissues and impairment in tissue repair in 82	  
db/db mice [4]. The recruitment of macrophages is also impaired and there is a 83	  
predominance of M1 pro-inflammatory macrophage subtype in the harmed area. 84	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The permanence of M1 macrophages in wound tissue increases the production of 91	  
inflammatory mediators and blocks inflammation resolution. As a consequence, the 92	  
progression to angiogenesis not occurs [3, 9]. 93	  
 Angiogenesis is defined as the formation of new vessels from preexisting 94	  
vessels [10]. It plays a critical role in wound healing, since it reestablishes the 95	  
supply of oxygen and nutrients to damaged area as well as promotes the migration 96	  
of cells that will build up the tissue. Angiogenesis is up regulated by growth factors 97	  
such as VEGF and ANGPT-2, that will promote the genesis of new vessels by 98	  
acting on endothelial cells [11]. On the other hand, it is down regulated by 99	  
angiostatin and TGF-β  (tumor growth factor-β ) that, not only, reduce the 100	  
synthesis of pro-angiogenic factors but also antagonize some of their effects [12]. 101	  
Then, both inflammation and angiogenesis play pivotal roles in injured tissue 102	  
repair. These two processes are impaired in diabetes, resulting in delayed wound 103	  
healing. Compounds that reestablish inflammation and angiogenesis and then 104	  
normalize the wound healing process are of great importance for diabetic patients.  105	  
Skin wounds are popularly treated with natural compounds such as nut oils 106	  
in developping countries. Although this provides the basis for the pharmaceutical 107	  
formulations of healing ointments, little is known about how these products act on 108	  
the wound healing process. We previously reported that oral administration of pure 109	  
linoleic acid (LA), an abundant fatty acid of nut oils, improves the wound healing 110	  
process in non-diabetic animals [13]. LA (18:2, ω-6) is an essential fatty acid 111	  
widely present in the western diet. LA constitutes 40% of the fatty acids in the 112	  
human skin and plays an important role for its function. However, there is no 113	  
consense about the effects of LA on inflammatory response yet. We reported that 114	  
oral administration of LA has pro- and anti-inflammatory effects in non-diabetic 115	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rats. LA increased the influx of inflammatory cells into the injured tissue, changed 121	  
neutrophil [14] and macrophage [15] fatty acid composition, and reduced the 122	  
production of cytokines and reactive oxygen species (ROS).  123	  
The information above led us to investigate the effects of oral administration 124	  
of LA on skin repair in diabetic rats. The key steps of wound healing, inflammation 125	  
and angiogenesis, were assessed. We hypothesized that LA may hasten wound 126	  
healing by acting on inflammatory response and angiogenesis.  To test this 127	  
hypothesis the experiments were performed in vivo in streptozotocin-induced 128	  
diabetic rats orally suplemented with pure LA.  129	  
 130	  
Materials and methods 131	  
 132	  
Animals  133	  
Male Wistar rats (from the Institute of Biomedical Sciences, Sao Paulo 134	  
University, Brazil) were maintained at 23oC under a light: dark cycle of 12:12 h and 135	  
received food (Nuvital, Curitiba, Brazil, containing 22% of protein, 4,5% of fat, 136	  
40,8% of carbohydrate and 8% of fiber) and water ad libitum. Linoleic acid 137	  
constitutes 40 % of the fatty acids in the chow. The complete fatty acid composition 138	  
of chow was previously published [14]. The Animal Care Committee of the Institute 139	  
of Biomedical Sciences approved the experimental procedure of this study 140	  
(Protocol number: 86).  141	  
 142	  
 143	  
 144	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Induction of diabetes mellitus  148	  
Type I diabetes mellitus was induced by streptozotocin injection as 149	  
previously reported [16]. This drug destroys pancreatic beta cells resulting in a 150	  
marked reduction in insulin release and consequently hyperglycemia. Diabetes 151	  
was confirmed three days after induction by blood glucose concentrations above 152	  
250 mg/dL as determined by the Accu-Check Active glucometer (Roche, 153	  
Mannheim, Germany). After ten days, diabetic animals were divided into two 154	  
groups: untreated diabetic (D) and diabetic that received oral LA supplementation 155	  
(DLA) (Fig 1).  156	  
 157	  
Administration of LA 158	  
  Oral administration of pure LA (Sigma-Aldrich Co, St Louis, MO, USA) was 159	  
initiated ten days after diabetes induction and maintained daily during the 160	  
experimental period. Unesterified LA, at a dose of 0.22 g/kg b.w, was administered 161	  
by gavage. The total calories associated with LA dose are low (1.98 cal/day) and 162	  
so, we used water administration as control [14]. The D group received water 163	  
(same LA volume). Considering the chow FA composition [14] and the food intake 164	  
(g/day) of the animals (data not shown), the LA dose used in the present study 165	  
represents an increase of 7% in the total ingestion of LA compared with the chow 166	  
diet.  167	  
 168	  
Skin wound induction 169	  
After five days of LA administration, the animals were anesthetized with 170	  
xilazine (7 mg/kg b.w.) and ketamine (14 mg/kg b.w.) and an area of 10 mm2 in 171	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dorsal region skin was shaved and removed by surgery. Animals were killed by 177	  
overdose of the anesthetics xilazine (21 mg/kg b.w.) and ketamine (42 mg/kg b.w.), 178	  
1, 3, 7 or 14 days after the surgery. 179	  
 180	  
Determination of wound tissue fatty acid composition 181	  
  The fatty acid composition of the wounds was determined by gas 182	  
chromatography (GC) as previously described [17]. Results of individual fatty acids 183	  
are expressed as percentage of total fatty acids. 184	  
 185	  
Skin wound closure assessment  186	  
Animals were anesthetized with isoflurane. The wounds were daily 187	  
photographed using a Sony cyber shot camera (model DSC-S950S 10 mP; 4 x 188	  
Optical zoom) by the same examiner, as previously described [13]. Wound closure 189	  
was defined as a reduction of wound area and results are expressed as 190	  
percentage of the original wound area. 191	  
 192	  
Eicosanoid measurements in wound tissue  193	  
The concentrations of leukotriene B4 (LTB4) and 15 (S) 194	  
hydroxyeicosatetraenoic acid (15(S)-HETE) were measured in scar tissue 195	  
homogenates using ELISA kits according to manufacturer's instructions (Cayman 196	  
Chemical, Ann Arbor, MI, USA). 197	  
 198	  
 199	  
 200	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Histological examination of the wound tissue 203	  
  Wound lesions with adjacent normal skin were removed, fixed in Bouin for 204	  
24 h at room temperature, processed and embedded in Paraplast®. Seven µm 205	  
sections were stained with hematoxilin/eosin to evaluate the general morphology of 206	  
the wound.  207	  
 208	  
Morphometric analysis of blood vessels 209	  
Digital photomicrographs were obtained using a Leitz Aristoplan optical 210	  
microscope (Leica) with a 20x objective and a Nikon (DS-Ril) camera. The NIS-211	  
Elements software was employed for image capturing. Only the dermal wound 212	  
region, just below the crust, was photographed (2-5 pictures per animal, 3-4 213	  
animals per group). The Image J public software (NIH, Bethesda, US) was used for 214	  
morphometric analysis using the grid plugin. A grid of 130 points was used in each 215	  
photograph and the number of points observed in the interior of small blood 216	  
vessels was counted and expressed as percentage of the total points, representing 217	  
the area occupied by vessels.  218	  
 219	  
Cytokine contents in wound tissue  220	  
Wound lesions removed at 1, 3 and 7 days after lesion induction were 221	  
wrapped up in aluminium paper, dropped into dry ice and kept frozen (-80°C). 222	  
CINC-2αβ , IL-1β , TNF-α , IL-6 and VEGF were assessed by ELISA as 223	  
previously described [13] using the Duo Set kit (R&D System, Minneapolis, MN, 224	  
USA) and normalized by protein concentration as measured by the Bradford 225	  
method [18]. 226	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Real-time polymerase chain reaction  231	  
 Total RNA was extracted (RNAeasy Mini Kit, Qiagen, Venlo, Netherlands) 232	  
from wound tissue and reverse-transcribed using the High-Capacity cDNA Reverse 233	  
Transcription kit (Applied Biosystems, Foster City, CA, USA). Reactions were 234	  
performed using SYBR-Green PCR master mix (Invitrogen, Carlsbad, CA, USA) in 235	  
a Rotor Gene Q (Qiagen, Germantown, Maryland, MD, USA). mRNA expression 236	  
was normalized by the D values in unwounded skin.  The sequences of the primers 237	  
used are described in the S1 Table.  238	  
 239	  
Measurement of NF-KB and AP-1 activation in wound 240	  
tissue  241	  
 Wound tissue removed at 1 and 24h after lesion was processed as previously 242	  
described [13, 19]. The blots were analyzed by scanner densitometry (Image 243	  
Master 1D, Amersham Biosciences) and results expressed as arbitrary units in 244	  
relation to diabetic animals.  245	  
 246	  
Statistical Analysis  247	  
Comparisons between groups were performed using Student’s t test. In 248	  
some experiments (cytokines, skin fatty acid composition and mRNA expression), 249	  
two-way analysis of variance (ANOVA) and Bonferroni post-test were used. The 250	  
significance was set at p<0.05. 251	  
 252	  
 253	  
 254	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Results 258	  
All streptozotocin-induced diabetic animals used in this study had blood 259	  
glucose levels close to 400 mg/dL. None other plasma measurement (e.g. ketone 260	  
bodies) was considered for this purpose as also reported by others [16, 20, 21]. 261	  
The diabetes protocol used was established considering the animals lost around 262	  
10% of their body weight and they would not survive for longer period without 263	  
insulin administration. The diabetic rats were not treated with insulin due to its 264	  
direct effects on the wound healing process [20]. The combination of high 265	  
glycemia, intense weight loss and general catabolic state could compromise the 266	  
interpretation of results obtained in a condition of prolonged diabetes state. Ten 267	  
days after streptozotocin-induced diabetes, a full-thickness biopsy was performed 268	  
and wound closure was assessed over time. The diabetic condition protocol used 269	  
did delay wound healing as indicated by the analysis of wound closure in control 270	  
(non-diabetic) and diabetic (non-treated) rats. 271	  
 Pure LA was orally administered to diabetic rats daily for 5 days prior to the 272	  
full-thickness biopsy and then until wound closure (Fig 1). The dose (0.22 273	  
g/kg/day) of LA and the duration of the administration did not induce any change in 274	  
the nutritional status of the animals (data not shown). The amount of LA given is 275	  
unlikely to have increased plasma ketone body levels. In fact, the dose of LA given  276	  
represents an increase of 7% in the total ingestion of LA compared with the chow 277	  
diet.  278	  
 279	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Oral administration of LA changed skin fatty acid 284	  
composition and modulated eicosanoid production in 285	  
wound tissue  286	  
We previously reported that the same treatment protocol increases the 287	  
proportion of LA in neutrophils [14] and macrophages [15]. LA increased 288	  
eicosadienoic (EDA) percentages on unwounded skin.  On the 7th day, LA elevated 289	  
the adrenic acid (AdA) percentages in wound tissue (Fig 2a).  290	  
The concentrations of LTB4 and 15(S)-HETE, two eicosanoids derived from 291	  
AA, which can be generated from LA (Fig 2b) were measured. Concentrations of 292	  
both eicosanoids were increased in the wound tissue one-day post-wounding and 293	  
were reduced after 3 and 7 days (15(S)-HETE) or 14 days (LTB4) in the DLA group 294	  
(Fig 2c). 295	  
 296	  
LA improved skin repair in diabetic rats  297	  
Fourteen days post-wounding, the original wound area was reduced by over 298	  
95% in the control group being fully closed by day 18 (Fig 3a). In comparison, 299	  
wound closure was much slower in diabetic animals. At the 7th day after wound 300	  
induction, diabetic animals had a larger wound area (p=0.002) than the control 301	  
group (D: 56 ± 2% vs. C: 34 ± 3%, mean ± SEM of 5-9 animals per group) (Fig 3a). 302	  
The delay in wound healing remained in diabetic animals and wounds were not 303	  
fully healed up to 18 days after induction.   304	  
Administration of LA hastened wound closure in diabetic rats (Fig 3b), an 305	  
effect that was independent of any change in glycemia (Fig 3c). The wound area 306	  
was reduced in the DLA group from the 14th to the 18th day post-wounding in 307	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   12	  
relation to D animals (Fig 3b). In order to verify if the effect on wound closure was 318	  
specific for LA, we performed the same analysis in diabetic rats treated with pure 319	  
oleic acid (OA), a monounsaturated 18-carbon chain fatty acid (S1 Fig). In contrast 320	  
to the effect of LA, OA caused a delay in the wound closure of diabetic rats (DOA 321	  
group) when compared to D animals but did not modify glycemia (S1 Fig). Taking 322	  
together, these results suggest that the improvement in wound healing is specific 323	  
for LA treatment. 324	  
  325	  
LA induced inflammatory cell migration and increased 326	  
formation of new vessels in wound tissue 327	  
Histological analysis of wounds from diabetic rats exhibited inflammation in 328	  
the dermis on the first day and intense neutrophil influx into the tissue from the 3rd 329	  
until to the 14th day post-wounding (Fig 4a). A few vessels were observed in 330	  
wounds of diabetic rats (Fig 4a).  331	  
Wounds were more inflamed in DLA group than in D animals on the first day 332	  
after wounding. Significant edema and high number of neutrophils were found in 333	  
the crust (Fig 4a). On the 3rd day, neutrophils were abundant at the surface of the 334	  
wound but in lower number than in the D group. There were more newly formed 335	  
vessels from the 3rd day until the 14th day after wounding in the DLA group in 336	  
relation to D animals (Figs 4b and 4c).  337	  
To explain the increase in vessel number observed in the DLA group, we 338	  
measured mRNA expression of tissue factors that regulate angiogenesis. Although 339	  
there was no difference in TGF-β expression, the concentration of VEGF was 340	  
elevated in DLA rats (Fig 4d), 7 days after wound induction. Considering this effect 341	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on VEGF, we analysed the expression of other pro-angiogênic factors at the 7th 350	  
day after tissue injury and observed that DLA increased ANGPT-2 mRNA 351	  
expression but did not alter eNOS (endothelial nitric oxide synthase) expression 352	  
(Fig 4e). These effects of LA were in agreement with the presence of new vessels 353	  
observed in the histological analysis (Figs 4a, 4b and 4c). Thus, LA induced 354	  
migration of inflammatory cells and increased the formation of new vessels in 355	  
wound tissue. 356	  
 357	  
LA affected both the early and the late cell recruitment  358	  
In order to evaluate the kinetics of inflammatory cell migration into wound 359	  
tissues, mRNA expression of neutrophil (myeloperoxidase - MPO) and 360	  
macrophage (F4/80) markers were measured during the wound healing process. 361	  
MPO activity and chemokine concentrations were also measured at different time 362	  
points in the wound tissue. LA increased MPO mRNA expression and activity one 363	  
hour after wound induction. This was followed by elevation in CINC-2αβ, an 364	  
important neutrophil chemoattractant agent (Fig 5). The increase in MPO mRNA 365	  
expression persisted until the 1st day after wound induction.  366	  
After neutrophils, the next cell population that migrates into an injured area 367	  
is macrophage. LA did not change F4/80 (macrophage marker) expression during 368	  
the inflammatory phase of wound healing (Fig 6a). However, LA diminished it at 7th 369	  
day. This result was followed by reduction in the contents of chemoattractant 370	  
cytokines (MIP-1 and MCP-1) and of iNOS expression (Fig 6b) that is increased in 371	  
activated macrophage [22]. So, LA treatment accelerated the early migration of 372	  
neutrophils through, at least in part, an increase in production of chemoattractants 373	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or neutrophil responsiveness to them. LA also modified migration of macrophages 380	  
(later) and production of macrophage-related chemoattractants. 381	  
 382	  
LA hastened the inflammatory phase  383	  
TNF-α concentration was raised in wounds on days 3 and 7 after lesion in 384	  
the DLA group in comparison to D rats (Fig 7). We did not observe any change in 385	  
IL-6 or IL-1β levels between the experimental groups (Fig 7). We also evaluated 386	  
activation of NF-κB and AP-1 in the wound tissue. No alteration was observed in 387	  
NF-κB activation. However, LA inhibited AP-1 activation 1 and 24 hours after 388	  
wound induction in diabetic animals (Fig 8).  389	  
Oral administration of LA hastened wound healing inflammation and 390	  
angiogenesis steps in diabetic rats by: 1) increasing inflammatory cell influx 391	  
through chemoattractant agent (CINC-2αβ) production and LTB4 generation; 2) 392	  
regulation in gene expression (MIP, MCP and iNOS), through AP-1 modulation; 3) 393	  
induction of vessel formation via production of pro-angiogenic factors (ANGPT-2 394	  
and VEGF). 395	  
  396	  
Discussion 397	  
 The animals herein used had a glycemia around 400 mg/dL (not affected by 398	  
the treatment with LA or wound process). Despite the short period of diabetes 399	  
impaired in wound healing was reported, in comparison to non-diabetic animals, 400	  
which resembles the human condition. Oral administration of LA to diabetic rats 401	  
hastened the influx of neutrophils (early), reduced macrophage (late) abundance, 402	  
and modulated the production/release of cytokines (CINC-2αβ and TNF-α), 403	  
Hosana Gomes  Rodrig…, 12/10/16 18:05
Formatted: Font:16 pt
Hosana Gomes  Rodrig…, 12/10/16 08:44
Deleted: ure404	  
Hosana Gomes  Rodrig…, 12/10/16 08:44
Deleted: ure405	  
Hosana Gomes  Rodrig…, 12/10/16 08:44
Deleted: ure406	  
Hosana Gomes  Rodrig…, 12/10/16 17:45
Deleted: 407	   ... [1]
Hosana Gomes  Rodrig…, 12/10/16 18:05
Formatted: Font:18 pt
	   15	  
growth factors (VEGF) and eicosanoids (LTB4 and 15(S)-HETE) that drive the 409	  
healing process. These modifications in LA treated rats were associated with new 410	  
vessel formation and improvement of the wound healing process.  411	  
In order to examine if the effects of LA on wound healing process were due 412	  
to LA incorporation in the skin, we evaluated skin fatty acid composition by gas 413	  
chromatography (GC). Although no differences were observed in LA or AA 414	  
incorporation, oral administration of LA increased eicosadienoic  (EDA – 20:2 ω-6) 415	  
and adrenic acid (AdA - 22:4ω-6) incorporation (Fig 2a).  EDA is a product of LA 416	  
elongation that also modifies the inflammatory response, however, in a less 417	  
intense manner when compared to LA or AA [23]. AdA is an AA elongation 418	  
product, which can be metabolized to dihomo-eicosanoids or docosanoids [24, 25]. 419	  
A reduction in AdA formation has been described in type 1-diabetes [26]. 420	  
Importantly, AdA reduces AA metabolism and inhibits AA-derived eicosanoid 421	  
formations [27]. In the present study, LA increased AdA incorporation and reduced 422	  
15(S)-HETE (Fig 2c).  423	  
15-HETE plays a key role in the early phase of wound healing since it 424	  
controls clot formation through platelet aggregation and thrombin production [28]. 425	  
Long standing release of 15-HETE is positively associated with wound tissue 426	  
infiltration of neutrophils and macrophages [29]. The presence of 15-HETE in the 427	  
latter phase of wound healing reflects a persistent influx of inflammatory cells into 428	  
the tissue and consequently wound chronification.  429	  
Fatty acids can generate a wide range of bioactive molecules named 430	  
oxylipins [30]. Oxylipins are products formed by PUFA oxidation and the most well 431	  
known class is the AA-derived eicosanoids [30]. However, they can also be derived 432	  
from LA such as 13 hydroxyoctadecadienoic acid (13-HODE) and 9,10-cis epoxide 433	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of linoleic acid (9,10 EpOME). Considering that HODE and EpOME oxilipins can 444	  
modulate inflammatory responses, a limitation of the present study is the fact we 445	  
did not measure these molecules during the wound healing process. 446	  
Diabetes mellitus is associated with chronic inflammation and poor wound 447	  
healing [31]. The inflammatory phase of wound healing in diabetes exhibits 448	  
accumulation and persistence of primed inflammatory cells in the lesion area [32], 449	  
resulting in exacerbated production of pro-inflammatory mediators that cause 450	  
surrounding tissue damage and impairs wound resolution [3, 31, 33].   451	  
During inflammation, leukocyte recruitment cascade, a sequential adhesive 452	  
interaction between leukocytes and endothelial cells, takes place [34]. LA 453	  
administration induced neutrophil infiltration in the first hours after wounding that 454	  
returned to basal values 3 days latter. The possible mechanisms involved in LA-455	  
induced cell migration are: increased adhesion molecule expression in leukocytes 456	  
[14] and endothelium [35] and release of chemoattractants such as MCP, LTB4 457	  
and CINC-2αβ [36]. The earlier expression of CINC-2αβ induced by LA, also 458	  
reported in the present study (Fig 5), is associated with an increase in neutrophil 459	  
influx into damaged tissue and with acceleration of colonic wound healing [37]. 460	  
Once in the injured area, neutrophils phagocyte dead cells and microorganisms 461	  
and produce cytokines that attract macrophages to wounded site. 462	  
Macrophages modify their phenotype in response to the wound 463	  
environment. Due to their plasticity, different states of polarization were described 464	  
for these cells, in which M1 (pro-inflammatory) and M2 (pro-resolution) are the 465	  
extremes [38]. In a short time wound healing, the switch of M1 to M2 macrophages 466	  
hastens the resolution of inflammation enabling the progression to the proliferative 467	  
phase [39]. On the other hand, in chronic wounds, the persistence of M1 468	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macrophages in the tissue exacerbates the inflammatory response and blocks the 480	  
progression to wound resolution [3].  481	  
Considering the importance of macrophages on wound healing, we 482	  
investigated if LA could influence their recruitment to the wound area. Although we 483	  
did not analyze M1/M2 markers, we found that LA diminished the expression of a 484	  
global macrophage marker (F4/80) and reduced the production macrophage 485	  
derived chemokines (MCP-1 and MIP-1) in the late inflammatory phase (7 days). 486	  
MCP-1 is a chemokine produced by several cell types including keratinocytes, 487	  
endothelial cells and resident macrophages, which induces migration of 488	  
inflammatory cells to injured tissue. Maximum expression of MCP-1 occurs 1-2 489	  
days after wounding and declines progressively until to the 7th day of the wound 490	  
healing process in control conditions [40].  491	  
We have previously demonstrated that LA induces transient AP-1 activation 492	  
in skin of non-diabetic rat [13], favoring the recruitment and activation of 493	  
inflammatory cells. The effect was not found herein in diabetic rat. LA reduced AP-494	  
1 activation at 1 and 24 hours after wounding. Neub et al. [41] stated that reduction 495	  
in AP-1 activity is needed to restore normal wound healing and prolonged AP-1 496	  
activation is described in chronic wounds [42]. The modulation of AP-1 activation in 497	  
skin is shared by other fatty acids such as docosahexaenoic acid (DHA) and by 498	  
eicosanoids such as 13-hydroxyoctadecadienoic acid (13-HODE) and 15-499	  
hydroxyeicosatrienoic acid (15-HETrE) [43]. These reports together indicate that 500	  
LA modulates recruitment of cells through inhibition of AP-1 activity and 501	  
consequent reduction on chemokine production.  502	  
After recruitment, leukocytes produce a range of inflammatory mediators 503	  
such as cytokines, ROS, and growth factors to resolve inflammation. IL-6, IL-1β 504	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and TNF-α play a very important role in this process. IL-6 promotes the migratory 511	  
response of epithelial cells [44] and wound remodeling [45]. IL-6 deficient mice 512	  
exhibit impaired angiogenesis, macrophage infiltration and re-epithelization, 513	  
resulting in delayed wound healing [46]. IL-1β inhibits type I collagen production 514	  
and upregulates metalloproteinase-1, which degrades collagen fibers [47]. 515	  
Collagen is the main component of the extracellular matrix and plays an important 516	  
role in the wound healing remodeling [48]. The reduction in type I collagen induces 517	  
premature collagen synthesis and poor healing. 518	  
TNF-α  is an important regulator of cell migration. Naaldijk et al. [49] 519	  
reported that the presence of TNF-α in the medium increases migration of 520	  
mesenchymal stem cells in a transwell assay. The migratory cell response plays a 521	  
critical role in the proliferative phase of wound healing. TNF-α also induces 522	  
angiogenesis in vivo [50] and in vitro [51] through increased VEGF production. 523	  
Increased TNF-α and VEGF production in diabetic animals treated with LA 524	  
explains the augmented number of new vessels and improved healing. Increased 525	  
VEGF levels and number of new vessels formed support the proposition that LA 526	  
induces angiogenesis.  527	  
Angiogenesis is necessary to deliver immune cells, nutrients and oxygen 528	  
and to remove debris from the damaged tissue. Impairment in formation of new 529	  
blood vessels retards the healing process and induces ulceration [52]. There is a 530	  
wide range of growth factors that regulate angiogenesis [52-54]. Diabetes per se 531	  
leads to increased TGF-β expression during tissue repair. High levels of TGF-β 532	  
increase extracellular matrix deposition that impairs the vascularization process 533	  
[55, 56]. Geng et al. [55] reported that there is an inverse correlation between TGF-534	  
β expression and VEGF concentration in colon tumors. TGF-β reduces VEGF 535	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stability by inducing ubiquitination and degradation of this growth factor, with no 548	  
effect on VEGF mRNA levels [55]. 549	  
Growth factors and cytokines released during inflammation are involved in 550	  
the abluminal sprouting and formation of new vessels from an existing vessel [57-551	  
59]. Nishioka et al. [60] described that in vivo administration of LA induces 552	  
angiogenesis through angiostatin suppression. Angiostatin is a proteolytic fragment 553	  
of plasminogen and suppresses angiogenesis by inhibiting endothelial cell 554	  
proliferation and migration and by inducing endothelial cell apoptosis [61]. In the 555	  
present study, we did not detect angiostatin mRNA expression seven days after 556	  
the wound in any group (data not shown). However, LA increased VEGF 557	  
production and expression of ANGPT-2. This latter protein is induced by growth 558	  
factors such as VEGF after endothelial cell [11] and/or fibroblast/myofibroblast [62] 559	  
activation. The presence of ANGPT-2 primes endothelial cells to respond to 560	  
inflammatory cytokines, resulting in expression of adhesion molecules and 561	  
transmigration of inflammatory cells [11]. LA increased the production of pro-562	  
angiogenic factors, which might be associated with elevation in vascularization.   563	  
These effects of LA are in agreement with the presence of new vessels observed 564	  
in the histological analysis (Figs. 4a, 4b and 4c). 565	  
 In summary, oral administration of LA to diabetic animals brought forward 566	  
the inflammatory response and induced angiogenesis. The pro-healing effects of 567	  
LA hasted the healing process in diabetic rats. 568	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Figure Legends 853	  
Fig 1. Experimental protocol.  854	  
 855	  
Fig 2. Fatty acid composition and eicosanoids production during wound 856	  
healing. (a) Fatty acid composition in wound tissue from diabetic rats (D) and 857	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diabetic rats treated with linoleic acid (DLA). Results are presented as mean + SD. 867	  
D (3 rats) and DLA (7 rats). (*) Indicates significant differences between D and 868	  
DLA rats (p<0.001). (b) Scheme showing LA metabolism and generation of 869	  
eicosanoids. (c) LTB4 and HETE-15 (S) concentrations in wound tissues from 870	  
diabetic rats (D) and diabetic rats treated with linoleic acid (DLA). Results are 871	  
presented as mean + SD. D (3 rats) and DLA (5 rats). (*) Indicates significant 872	  
differences between D and DLA rats (LTB4 1d – p=0.002; LTB4 14d – p=0.02; 873	  
HETE-15 (S) 1d – p=0.03; HETE-15 (S) 3d – p=0.001; HETE-15 (S) 7d – p=0.04). 874	  
 875	  
Fig 3. Time course of wound healing and glycemia. (a) Macroscopic and time 876	  
course of wound closure in control (C) and diabetic rats (D). (*) Indicates significant 877	  
differences among C versus D (p=0.006) (b) Macroscopic and time course of 878	  
wound closure in diabetic (D) and diabetic rats treated with LA (DLA) (*) Indicates 879	  
significant differences between D and DLA (p=0.02). Representative photos of the 880	  
wound tissue obtained during the time-course of 18 days. Results are presented as 881	  
mean + SD. D (5 rats) and DLA (9 rats). (c) Glycemia of rats during the wound 882	  
healing process: (D) diabetic; (DLA) diabetic rats treated with LA. Dashed line 883	  
indicates the mean of glycemia in control rats. 884	  
 885	  
Fig 4. Histological analysis and angiogenic growth factors expression in 886	  
wound tissue. (a) Samples were isolated from diabetic rats (D) and diabetic rats 887	  
treated with linoleic acid (DLA) at the 1st, 3rd, 7th and 14th days after wounding. (b) 888	  
Representative new vessel formation in wound tissue from the D and DLA groups. 889	  
Samples were collected on the 7th day after wounding. (c) Vessels quantification. 890	  
Results are presented as mean + SD. D (4 rats) and DLA (5 rats). (*) Indicates 891	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significant difference between D and DLA (p=0.0001). (d) TGF-β  mRNA 897	  
expression and VEGF concentration in wound tissues from diabetic rats (D) and 898	  
diabetic rats treated with linoleic acid (DLA). Results are presented as mean + SD. 899	  
D (9 rats) and DLA (4 rats). (*) Indicates significant difference between D and DLA 900	  
(VEGF – p<0.01). (e) eNOS and ANGPT-2 mRNA expression in wound tissues 901	  
from diabetic rats (D) and diabetic rats treated with linoleic acid (DLA). Results are 902	  
presented as mean + SD. D (9 rats) and DLA (4 rats). (*) Indicates significant 903	  
difference between D and DLA (ANGPT-2 – p=0.01). V: vessel. DE: derm. 904	  
Objective 10X. 905	  
 906	  
Fig 5. Myeloperoxidase and CINC-2αβ  contents. Myeloperoxidase (MPO) 907	  
activity (1 hour), mRNA expression (1 h, 1, 3 and 7 days) and CINC-2αβ 908	  
concentration (1 h) in wound tissue. Results are presented as mean + SD. D (6 909	  
rats) and DLA (6 rats). (*) Indicates significant differences between D and DLA rats 910	  
(MPO activity – p=0.02; mRNA expression 1h 0.006; mRNA 1 day – p=0.03; CINC-911	  
2αβ – p=0.04). 912	  
Fig 6. Macrophages cell markers expression. (a) mRNA expression of F4/80 in 913	  
wound tissue 1 hour and 1-7 days after wounding. Results are presented as mean 914	  
+ SD. D (5 rats) and DLA (10 rats). (b) mRNA expression of MIP-1, MCP-1 and 915	  
iNOS in wound tissue from diabetic rats (D) and diabetic rats treated with linoleic 916	  
acid (DLA). Results are presented mean + SD. D (5 animals) and DLA (9 animals). 917	  
(*) Indicates significant differences between D and DLA rats (p<0.001) 918	  
 919	  
Fig 7. Cytokines production during wound healing. CINC-2αβ, IL-6, IL-1β 920	  
and TNF-α concentrations in wound tissue from diabetic rats (D) and diabetic rats 921	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treated with linoleic acid (DLA). Results are presented mean + SD. D (5 animals) 926	  
and DLA (6 animals). (*) Indicates significant differences between D and DLA rats 927	  
(TNF-α 3d – p<0,05; TNF-α 7d – p<0.01)  928	  
 929	  
Fig 8. Transcription factors activation. NF-KB and AP-1 activation in wound 930	  
tissues from diabetic rats (D) and diabetic rats treated with linoleic acid (DLA). 931	  
Results are presented as mean + SD. D (5 animals) and DLA (8 animals). (*) 932	  
Indicates significant difference between D and DLA rats (AP-1 1 h – p=0.02; AP-1 933	  
24hs – p=0.001) 934	  
 935	  
Supplemental Information 936	  
 937	  
S1 Table. Primer sequences. 938	  
 939	  
S1 Fig. Time course of wound closure in diabetic (D) and diabetic treated 940	  
with oleic acid (DOA) rats. Results are presented as mean + SD of 7 animals in 941	  
each group. (#) Indicates differences in relation to D (10d – p=0.04; 16d – p=0.03; 942	  
18d – p=0.03). Glycemia of rats during the wound healing process: (D) diabetic; 943	  
(DOA) diabetic rats treated with OA. Dashed line indicates the mean of glycemia in 944	  
control rats. 945	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